Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Effects of the Combination of Atomoxetine and Oxybutynin on OSA Endotypic Traits

CHEST Journal(2020)10.1016/j.chest.2020.01.012Source: DataRank Database

Effects of the Combination of Atomoxetine and Oxybutynin on OSA Endotypic Traits is a research paper published in CHEST Journal (2020). On theSindex it has a DataRank of 0. It has been cited 128 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access128 citations

Download PDF

Cite:

Linked data & code

doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (8 grants)Impact (FWCI 8.36)OA: greenTopics (46)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (9)

Ludovico Messineo ORCID,Ali Azarbarzin ORCID,Daniel Vena ORCID,Lauren B. Hess ORCID,N. Calianese ORCID

Live enrichment

PubMed:32006590 PMC:PMC7268440 OpenAlex:https://openalex.org/W3004160311

NHLBI NIH HHS

Grant: R01 HL128658

NHLBI NIH HHS

Grant: P01 HL095491

NHLBI NIH HHS

Grant: R01 HL102321

NCRR NIH HHS

Grant: UL1 RR025758

National Institutes of Health

Grant: 3P01HL095491-02S1

Mechanisms of State Switching in Sleep and Sleep Apnea

National Institutes of Health

Grant: 2R01HL102321-10A1

Predicting response to non-PAP therapies in OSA using PSG-derived endotypes

National Institutes of Health

Grant: 3UL1RR025758-04S1

Harvard Clinical and Translational Science Center (UL1)

National Institutes of Health

FWCI

8.36

Citation Percentile

1.0%

Citation Trend

2020

2021

2022

2023

2024

2025

2026

greenLicense: Elsevier TDM

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/7268440

publisherhttps://api.elsevier.com/content/article/PII:S0012369220301355?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S0012369220301355?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.chest.2020.01.012

Fields of Study

Obstructive Sleep Apnea ResearchSleep and related disordersChronic Obstructive Pulmonary Disease (COPD) Research03 medical and health sciences0302 clinical medicine

MeSH Terms

Atomoxetine HydrochlorideDouble-Blind MethodDrug Therapy, CombinationFemaleHumansMaleMandelic AcidsMiddle AgedParasympatholyticsSleepTreatment OutcomePolysomnographyCross-Over StudiesAdrenergic Uptake InhibitorsSleep Apnea, ObstructiveContinuous Positive Airway Pressure

Keywords

AtomoxetineOxybutyninMedicineClinical psychologyAttention deficit hyperactivity disorderMethylphenidateOsa PhenotypesOsa PharmacotherapyNoradrenergic And AntimuscarinicMaleSleep Apnea, ObstructiveCross-Over StudiesAdrenergic Uptake InhibitorsContinuous Positive Airway PressurePolysomnographyParasympatholyticsMiddle AgedAtomoxetine HydrochlorideTreatment OutcomeDouble-Blind MethodHumansMandelic AcidsDrug Therapy, CombinationFemaleSleep

Sustainable Development Goals

SDG 0: Good health and well-being

Effects of the Combination of Atomoxetine and Oxybutynin on OSA Endotypic Traits

FAIR Checklist

Authors (9)

Funding (8 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)